Analysis of systemic inflammatory biomarkers in neuroendocrine carcinomas of the lung: prognostic and predictive significance of NLR, LDH, ALI, and LIPI score.
Antonio GalvanoMarta PeriAurelia Ada GuariniMarta CastigliaAntonino GrassadoniaMichele De TursiLuciana IrtelliSergio RizzoAlessandro BertaniValerio GristinaNadia BarracoAntonio RussoClara NatoliViviana BazanPublished in: Therapeutic advances in medical oncology (2020)
This study demonstrated that systemic inflammatory biomarkers could facilitate the understanding of survival differences in the clinical management of lung NEC patients, underlying the need for prospective biomarker-driven studies in the immune checkpoint inhibitors setting.